Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

Clinical trial NCT00141700 · TERMINATED

Trial details

NCT number: NCT00141700
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's

Start date: 2003-03-01
Primary completion: 2005-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.